Systemic sclerosis: changes in the incidence rates in the Finnish population during the years 1999-2018.

IF 2.2 4区 医学 Q3 RHEUMATOLOGY Scandinavian Journal of Rheumatology Pub Date : 2024-01-01 Epub Date: 2023-07-13 DOI:10.1080/03009742.2023.2217620
S Kortelainen, M Käyrä, S Hurme, J Paltta, L Pirilä, J Huhtakangas
{"title":"Systemic sclerosis: changes in the incidence rates in the Finnish population during the years 1999-2018.","authors":"S Kortelainen, M Käyrä, S Hurme, J Paltta, L Pirilä, J Huhtakangas","doi":"10.1080/03009742.2023.2217620","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The aim of our study was to examine changes in the incidence of systemic sclerosis (SSc) in Finland using two different classification criteria.</p><p><strong>Method: </strong>Medical records of patients who had been registered with ICD-10 code M34 from 1999 to 2018 in two university hospitals were reviewed retrospectively. This period was divided into 5 year periods: 1999-2003, 2004-2008, 2009-2013, and 2014-2018. Using American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) 2013 criteria and clinical findings, we reclassified patients into four groups: diffuse SSc, limited SSc, sine SSc, or early SSc. In the same population, we also investigated whether the ACR 1980 criteria were fulfilled.</p><p><strong>Results: </strong>In 1999-2018, 246 new patients with SSc and 45 patients with early SSc were identified using ACR/EULAR 2013 criteria. Of these patients, 70 fulfilled the ACR 1980 criteria. Using ACR/EULAR 2013 criteria, the increase in new diagnoses was statistically significant when comparing the fourth period with the first period (p = 0.0012). The increase was due to a rise in limited SSc. Mean annual incidence rates in these groups were 0.9, 1.2, 1.9, and 2.8 per 100 000 inhabitants ≥ 16 years old. An increasing trend was also seen when using ACR 1980 criteria, but this was not statistically significant.</p><p><strong>Conclusion: </strong>The incidence of SSc increased during the period between 1999-2003 and 2014-2018 using ACR/EULAR 2013, but not using ACR 1980 criteria. The increase was detected within a limited SSc subclass, owing to more sensitive classification criteria.</p>","PeriodicalId":21424,"journal":{"name":"Scandinavian Journal of Rheumatology","volume":" ","pages":"29-35"},"PeriodicalIF":2.2000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scandinavian Journal of Rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/03009742.2023.2217620","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/7/13 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The aim of our study was to examine changes in the incidence of systemic sclerosis (SSc) in Finland using two different classification criteria.

Method: Medical records of patients who had been registered with ICD-10 code M34 from 1999 to 2018 in two university hospitals were reviewed retrospectively. This period was divided into 5 year periods: 1999-2003, 2004-2008, 2009-2013, and 2014-2018. Using American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) 2013 criteria and clinical findings, we reclassified patients into four groups: diffuse SSc, limited SSc, sine SSc, or early SSc. In the same population, we also investigated whether the ACR 1980 criteria were fulfilled.

Results: In 1999-2018, 246 new patients with SSc and 45 patients with early SSc were identified using ACR/EULAR 2013 criteria. Of these patients, 70 fulfilled the ACR 1980 criteria. Using ACR/EULAR 2013 criteria, the increase in new diagnoses was statistically significant when comparing the fourth period with the first period (p = 0.0012). The increase was due to a rise in limited SSc. Mean annual incidence rates in these groups were 0.9, 1.2, 1.9, and 2.8 per 100 000 inhabitants ≥ 16 years old. An increasing trend was also seen when using ACR 1980 criteria, but this was not statistically significant.

Conclusion: The incidence of SSc increased during the period between 1999-2003 and 2014-2018 using ACR/EULAR 2013, but not using ACR 1980 criteria. The increase was detected within a limited SSc subclass, owing to more sensitive classification criteria.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
系统性硬化症:1999-2018年间芬兰人口发病率的变化。
研究目的我们的研究旨在采用两种不同的分类标准,研究芬兰系统性硬化症(SSc)发病率的变化:方法: 我们对 1999 年至 2018 年期间在两所大学医院登记的 ICD-10 代码为 M34 的患者病历进行了回顾性审查。这一时期分为 5 年:1999-2003 年、2004-2008 年、2009-2013 年和 2014-2018 年。根据美国风湿病学会(ACR)/欧洲抗风湿联盟(EULAR)2013 年的标准和临床发现,我们将患者重新分为四组:弥漫性 SSc、局限性 SSc、正中型 SSc 或早期 SSc。在同一人群中,我们还调查了是否符合 ACR 1980 标准:结果:1999-2018年间,根据ACR/EULAR 2013年标准,共发现了246名新的SSc患者和45名早期SSc患者。其中,70 名患者符合 ACR 1980 标准。采用 ACR/EULAR 2013 标准,第四阶段与第一阶段相比,新确诊患者的增加具有统计学意义(p = 0.0012)。增加的原因是局限性 SSc 的增加。这些组别的年平均发病率分别为每 10 万名≥ 16 岁的居民中 0.9、1.2、1.9 和 2.8 例。采用 ACR 1980 标准时,发病率也呈上升趋势,但无统计学意义:结论:在1999-2003年和2014-2018年期间,采用ACR/EULAR 2013标准的SSc发病率有所上升,而采用ACR 1980标准的发病率则没有上升。由于采用了更敏感的分类标准,在有限的 SSc 亚类中发现了发病率的增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.70
自引率
4.80%
发文量
90
审稿时长
6-12 weeks
期刊介绍: Scandinavian Journal of Rheumatology is the official journal of the Scandinavian Society for Rheumatology, a non-profit organization following the statutes of the Scandinavian Society for Rheumatology/Scandinavian Research Foundation. The main objective of the Foundation is to support research and promote information and knowledge about rheumatology and related fields. The annual surplus by running the Journal is awarded to young, talented, researchers within the field of rheumatology.pasting The Scandinavian Journal of Rheumatology is an international scientific journal covering clinical and experimental aspects of rheumatic diseases. The journal provides essential reading for rheumatologists as well as general practitioners, orthopaedic surgeons, radiologists, pharmacologists, pathologists and other health professionals with an interest in patients with rheumatic diseases. The journal publishes original articles as well as reviews, editorials, letters and supplements within the various fields of clinical and experimental rheumatology, including; Epidemiology Aetiology and pathogenesis Treatment and prophylaxis Laboratory aspects including genetics, biochemistry, immunology, immunopathology, microbiology, histopathology, pathophysiology and pharmacology Radiological aspects including X-ray, ultrasonography, CT, MRI and other forms of imaging.
期刊最新文献
Global health in axial spondyloarthritis: thresholds for the Assessment of SpondyloArthritis international Society Health Index and the EuroQol score: analysis of the ASAS-PerSpA study. Incident rheumatoid arthritis in patients living in Turkey and in Denmark: a comparative clinical, genetic, and serological study. Mitophagy drives maldifferentiation of tissue-resident memory T cells in patients with rheumatoid arthritis. Pristimerin inhibits the progression of antibody-induced autoimmune arthritis. Risk factors for shoulder pain and stiffness in adults aged 44 and older: an 11-year longitudinal population-based study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1